Ownership Summary
Perspective Therapeutics, Inc. (NYSE:CATX) has 2 institutional investors that have filed 13F reports for the period ending December 2025.
- These investors collectively held 0.3% of Perspective Therapeutics's outstanding shares in December 2025, down from 1.6% in September 2025.
- Their total shares held in CATX decreased -79.5% quarter over quarter, and separately, investors owning Perspective Therapeutics increased 100.0% from a year ago.
- Activity in CATX broke down as 0 buyers, 1 sellers, and 1 unchanged among 2 total holders.
- In total, institutional investors held 250.5K shares in Perspective Therapeutics as of December 2025, down by 971.47K shares quarter on quarter, and up 100.5K shares year over year.
- PORTLAND INVESTMENT COUNSEL INC. holds the largest position in CATX at 250.0K shares as of December 31, 2025, or 0.34% of shares outstanding.
- The largest sales of CATX for the quarter ending December 2025 came from VESTOR CAPITAL, LLC (971.47K).
- Business Quant data shows the 2 biggest positions in Perspective Therapeutics as of December 2025 are held by PORTLAND INVESTMENT COUNSEL INC. (250.0K), VESTOR CAPITAL, LLC (502).